Sarcopenia in cancer survivors is associated with increased cardiovascular disease risk
- 168 Downloads
The aim of this study was to assess the association between sarcopenia and cardiovascular disease (CVD) risk in cancer survivors.
We analyzed a consecutive series of 683 cancer survivors from the Korean National Health and Nutritional Exam Survey (2008–2011 years). Sarcopenia was defined as the appendicular skeletal muscle mass divided by weight (Kg) < 1 standard deviation below the sex-specific healthy population aged 20–39 years. CVD risks were assessed using the Framingham Risk Score (FRS), which were divided by tertile. Predictors of higher shift of FRS tertile by sex were calculated by stratified ordinal logistic regression analyses.
Proportions of sarcopenia were 24.2% in males and 22.5% in females. Sarcopenic survivors were more likely to have a higher body mass index, waist circumference, blood pressure and fasting glucose level, and a lower high-density lipoprotein compared to those without sarcopenia. Sarcopenia was associated with a higher shift of FRS tertile (common odds ratio, 2.67; 95% confidence interval, 1.18–6.52, P < 0.001) in males. However, this association was not significant in female survivors.
Sarcopenia was associated with an increased CVD risk in Korean male cancer survivors. Interventions to prevent sarcopenia may be necessary to improve cardiovascular burden in cancer survivors.
KeywordsNeoplasm Sarcopenia Cardiovascular disease Risk assessments Nutrition survey
Compliance with ethical standards
Conflict of Interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was conducted solely using a de-identified research dataset, with approval of exemption from review by the Institutional Board and Ethics Committee (IRB number 2017-23).
Informed consent was not required for this study, given the use of secondary data that contained no patient identifiers.
- 4.Rugbjerg K, Mellemkjær L, Boice JD, Køber L, Ewertz M, Olsen JH (2014) Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943–2009. J Natl Cancer Inst 106(6). https://doi.org/10.1093/jnci/dju110
- 9.Mouridsen H, Keshaviah A, Coates AS, Rabaglio M, Castiglione-Gertsch M, Sun Z, Thürlimann B, Mauriac L, Forbes JF, Paridaens R, Gelber RD, Colleoni M, Smith I, Price KN, Goldhirsch A (2007) Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial. J Clin Oncol 25(36):5715–5722. https://doi.org/10.1200/JCO.2007.12.1665 CrossRefPubMedGoogle Scholar
- 11.Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763. https://doi.org/10.1093/oxfordjournals.aje.a009520 CrossRefPubMedGoogle Scholar
- 12.Muscaritoli M, Anker S, Argiles J et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG)“cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29(2):154–159. https://doi.org/10.1016/j.clnu.2009.12.004 CrossRefPubMedGoogle Scholar
- 14.Villaseñor A, Ballard-Barbash R, Baumgartner K, Baumgartner R, Bernstein L, McTiernan A, Neuhouser ML (2012) Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL study. J Cancer Surviv 6(4):398–406. https://doi.org/10.1007/s11764-012-0234-x CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Prado CM, Baracos VE, McCargar LJ et al (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15(8):2920–2926. https://doi.org/10.1158/1078-0432.CCR-08-2242 CrossRefPubMedGoogle Scholar
- 16.Fukuda Y, Yamamoto K, Hirao M, Nishikawa K, Nagatsuma Y, Nakayama T, Tanikawa S, Maeda S, Uemura M, Miyake M, Hama N, Miyamoto A, Ikeda M, Nakamori S, Sekimoto M, Fujitani K, Tsujinaka T (2016) Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer 19(3):986–993. https://doi.org/10.1007/s10120-015-0546-4 CrossRefPubMedGoogle Scholar
- 17.Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, di Iorio A, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95(5):1851–1860. https://doi.org/10.1152/japplphysiol.00246.2003 CrossRefPubMedGoogle Scholar
- 18.Srikanthan P, Karlamangla AS (2011) Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and nutrition examination survey. J Clin Endocrinol Metab 96(9):2898–2903. https://doi.org/10.1210/jc.2011-0435 CrossRefPubMedGoogle Scholar
- 20.Haskell WL, Lee I-M, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A, American College of Sports Medicine, American Heart Association (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116(9):1081–1093. https://doi.org/10.1161/CIRCULATIONAHA.107.185649 CrossRefPubMedGoogle Scholar
- 22.Kim YS, Lee Y, Chung YS, Lee DJ, Joo NS, Hong D, Song G, Kim HJ, Choi YJ, Kim KM Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the fourth Korean National Health and nutritional examination surveys. J Gerontol A Biol Sci Med Sci 2012;67(10):1107–1113, DOI: https://doi.org/10.1093/gerona/gls071
- 23.Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, Kim KW, Lim JY, Park KS, Jang HC (2010) Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean longitudinal study on health and aging (KLoSHA). Diabetes Care 33(7):1652–1654. https://doi.org/10.2337/dc10-0107 CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Bu S, Ruan D, Yang Z, Xing X, Zhao W, Wang N, Xie L, Yang W (2015) Sex-specific prevalence of diabetes and cardiovascular risk factors in the middle-aged population of China: a subgroup analysis of the 2007–2008 China National Diabetes and metabolic disorders study. PLoS One 10(9):e0139039. https://doi.org/10.1371/journal.pone.0139039 CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Florin TA, Fryer GE, Miyoshi T, Weitzman M, Mertens AC, Hudson MM, Sklar CA, Emmons K, Hinkle A, Whitton J, Stovall M, Robison LL, Oeffinger KC (2007) Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. Cancer Epidemiol Biomark Prev 16(7):1356–1363. https://doi.org/10.1158/1055-9965.EPI-07-0048 CrossRefGoogle Scholar
- 38.Saidi O, Malouche D, O'Flaherty M, Ben Mansour N, A Skhiri H, Ben Romdhane H, Bezdah L (2016) Assessment of cardiovascular risk in Tunisia: applying the Framingham risk score to national survey data. BMJ Open 6(11):e009195. https://doi.org/10.1136/bmjopen-2015-009195 CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Kim YJ, Kim CH, Meta SSJ (2002) Analysis for the relation between Korean dietary factors and stomach cancer. J Korean Acad Fam Med 23(9):1098–1106Google Scholar
- 40.He J, Gu D, Chen J, Jaquish CE, Rao DC, Hixson JE, Chen JC, Duan X, Huang JF, Chen CS, Kelly TN, Bazzano LA, Whelton PK, GenSalt Collaborative Research Group (2009) Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study. J Hypertens 27(1):48–54. https://doi.org/10.1097/HJH.0b013e328316bb87 CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K, ACTS-GC Group (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357(18):1810–1820. https://doi.org/10.1056/NEJMoa072252 CrossRefPubMedGoogle Scholar
- 43.Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis report of the European working group on sarcopenia in older people. Age Ageing 39(4):412–423. https://doi.org/10.1093/ageing/afq034 CrossRefPubMedPubMedCentralGoogle Scholar